Advertisement
Advertisement
U.S. markets open in 4 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Albireo Pharma, Inc. (ALBO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
26.65+0.62 (+2.38%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close26.03
Open26.08
Bid0.00 x 800
Ask0.00 x 800
Day's Range25.75 - 28.19
52 Week Range20.30 - 43.41
Volume305,446
Avg. Volume187,890
Market Cap513.775M
Beta (5Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ALBO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Albireo Pharma, Inc.
    HALO: Lowering target price to $36.00HALOZYME THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $36.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
Advertisement
Advertisement